- Home
- FITB vs BDX Comparison
FITB vs BDX Comparison
Compare FITB & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FITB | BDX |
|---|---|---|
| Founded | 1858 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.5B | 54.6B |
| IPO Year | 2009 | 1998 |
Fundamental Metrics
Financial Performance| Metric | FITB | BDX |
|---|---|---|
| Price | $53.10 | $195.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 16 |
| Target Price | $61.49 | ★ $195.57 |
| AVG Volume (30 Days) | ★ 7.0M | 1.4M |
| Earning Date | 10-19-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.17% | 2.11% |
| EPS Growth | ★ 12.42 | N/A |
| EPS | 1.02 | ★ 1.59 |
| Revenue | $577,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $42.26 | N/A |
| Revenue Next Year | $9.45 | $2.34 |
| P/E Ratio | ★ $52.12 | $125.17 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $40.68 | $140.11 |
| 52 Week High | $59.50 | $213.08 |
Technical Indicators
Market Signals| Indicator | FITB | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 59.59 | 62.19 |
| Support Level | $52.61 | $195.63 |
| Resistance Level | $53.33 | $213.08 |
| Average True Range (ATR) | 1.05 | 3.95 |
| MACD | 0.48 | 1.14 |
| Stochastic Oscillator | 86.79 | 78.74 |
Price Performance
Historical ComparisonAbout FITB Fifth Third Bancorp
Fifth Third Bancorp is a midsize regional bank in the US, with total assets of around $300 billion as of June 2026. The bank closed its acquisition of Comercia in February 2026. Headquartered in Cincinnati, Ohio, Fifth Third has a strong presence in the US Midwest and is currently expanding in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and Treasury management, wealth and asset management, and capital markets.
About BDX Becton Dickinson and Company
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.